Unprecedented $10 million Federal Grant will boost the Valley

Translate to Spanish or other 102 languages!

methodist

- Advertisement -

Investment by Methodist Healthcare Ministries of South Texas, Inc. to stimulate improvements in behavioral health and chronic disease

Mega Doctor News

San Antonio, Texas Methodist Healthcare Ministries of south Texas, Inc., the largest private, faith-based funding source for healthcare services in South Texas, will announce during a special press conference in McAllen, Texas a major investment in the Rio Grande Valley thanks to an unprecedented federal grant.

- Advertisement -

The Social Innovation Fund (SIF), a key White House initiative and program of the Corporation for National and Community Service (CNCS), awarded $10 million in investments to MHM—the first-award from the SIF to a faith-based organization—to support its ‘Sí Texas: Social Innovation for a Healthy South Texas’ Project.

The objective of the Sí Texas Project is to stimulate improvements in behavioral health and chronic disease in South Texas, and to highlight integrated behavioral health models that are effectively improving health outcomes in communities with high rates of poverty, depression, diabetes, obesity and associated risk factors. The Sí Texas Project will target 12 counties that span the U.S.-Mexico border in South Texas—including Cameron, Hidalgo, Starr and Willacy counties in the Rio Grande Valley—and include grants made available to local agencies ranging from $250,000 to $2 million through an open, competitive application process.

Executive Team

Executive Team

Our team is dedicated to our mission of “Serving Humanity to Honor God.” Each team member brings the expertise, judgment, leadership and diversity of thought and experience required to make responsible decisions for all of our stakeholders.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Researchers Discover How Aggressive Brain Tumors Outsmart Treatment

For patients diagnosed with IDH-mutant glioma, an incurable brain tumor that often affects adults in their 30s and 40s, treatment typically works at first. However, the cancer almost always returns, and when it does, it frequently stops responding to treatment.

STHS Edinburg Solidifies Leadership in Advanced Care with Triple Surgical Reaccreditation

There’s no doubt that advancements in surgical technology are changing lives, shifting care away from traditional open procedures toward less invasive, more precise techniques that promote faster healing and improved outcomes.

STHS Heart Earns Level 3 Geriatric Emergency Department Accreditation

Health challenges can affect individuals at any stage of life, but the likelihood of complications rises significantly with age.

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
- Advertisement -